NHS Board appointments
August 9, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NHS, government
Further Commissioning Support Unit (CSU) managing directors have been announced by the NHS Board Authority.
UK doctors must prepare for the rise of the ‘ePatient’
August 9, 2012Medical Communications, Sales and Marketing ABPI, GPs, digital
Doctors and other healthcare professionals must prepare for the rise of ‘ePatients’ in the coming years and keep apace with …
ABPI appoints UK pharma team to head VBP discussion
August 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, VBP
The ABPI has announced the team which will represent the pharma industry in negotiations with the government to agree the …
Pfizer pays $60m in bribery cases
August 8, 2012Sales and Marketing DoJ, FDA, GSK, Janssen, Pfizer, Wyeth, bribery
Pfizer has been fined $60 million for making improper payments to doctors in Europe, Asia and the Middle East. The …
AstraZeneca and BTG sepsis drug fails
August 8, 2012Research and Development, Sales and Marketing AZD977, AstraZeneca, BTG, CytoFab, sepsis
AstraZeneca’s pipeline has suffered another blow with the troubled company halting development of an investigational sepsis drug following poor Phase …
Appointments made to NHS property services
August 8, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Charles Howeson, NHS
The company set up by the government to manage all the ex-PCT estate not transferred to providers (NHS Property Services), …
GSK’s Votrient gains new licence
August 8, 2012Sales and Marketing GSK, NICE, Votrient, soft cell sarcoma
GlaxoSmithKline has gained a new European licence for its cancer pill Votrient adding to its renal cell carcinoma licence. The …
Regeneron to expand workforce at New York facility
August 8, 2012Manufacturing and Production Arcalyst, Eylea, Regeneron, Zaltrap
Buoyant product sales at US biotech Regeneron have prompted the company to undertake a recruitment drive at its manufacturing facility …
Champix better than patches for smoking cessation
August 7, 2012Sales and Marketing Champix, FDA, Pfizer, Zyban, smoking
New research shows that Pfizer’s Champix is better than nicotine patch therapy at helping smokers kick the habit. A Pfizer …
Ticking all the Boxes
August 7, 2012Manufacturing and Production
Pharmaceutical packaging has many functions to perform but in the OTC area of the market brand owners and product manufactures …
GE and iBio expand plant production alliance
August 7, 2012Manufacturing and Production GE Healthcare, iBio, iBioLaunch
GE Healthcare and iBio have forged an alliance to commercialise plant-based technologies for the manufacture of biologic drugs and vaccines. …
Boehringer wins contract to make Servier’s gevokizumab
August 7, 2012Manufacturing and Production Boehringer Ingelheim, CMO, Servier, antibody
Boehringer Ingelheim’s contract manufacturing organisation (CMO) division will provide commercial-scale manufacturing of a new monoclonal antibody developed by Servier and …
AstraZeneca launches prostate cancer app
August 7, 2012Medical Communications AZ, AstraZeneca, PSA, Zoladex, diabetes, prostate
AstraZeneca has launched a new app that helps prostate cancer patients to monitor their PSA levels. It is not the …
Horizon Discovery appoints chief financial officer
August 7, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Horizon Discovery, Richard Vellacott
Horizon Discovery has announced the appointment of Richard Vellacott as chief financial officer. The firm which is a provider of …
What Does E-Detailing Entail? How E-Detailing is Shaping the Pharmaceutical Industry
August 7, 2012Sales and Marketing e-detailing, sales, sales reps
E-detailing has come at a time of great change in the pharmaceutical industry. The economic recession hit hard with pressure …
Pfizer/Janssen Alzheimer’s drug dropped after failure
August 7, 2012Research and Development, Sales and Marketing Alzheimer's, Janssen, Pfizer, bapineuzumab
Pfizer and Janssen have decided to drop their investigational Alzheimer’s drug bapineuzumab after it failed a second late-stage study. The …
Opposition mounting to EU’s API import regulations
August 7, 2012Manufacturing and Production API, EU, TBT, WTO, manufacturing
Changes to the EU’s rules governing the importation of active pharmaceutical ingredients (APIs) are being opposed by the governments of …
Merck’s Singulair faces generic rivals
August 7, 2012Sales and Marketing Merck, Singulair, generic erosion, patent
Merck has lost patent protection on its biggest selling drug Singulair, opening the floodgates for generic rivals. Merck’s drug brought …
Whitehead to GPs: don’t squeeze the drugs budget
August 7, 2012Medical Communications, Sales and Marketing ABPI, CCGs, GPs, NHS, PCTs, reform
GPs should value the drug industry and not seek to squeeze the drugs bill as their predecessors have done, says …
Sue NHS to ensure access to drugs, says NICE chief
August 6, 2012Lucentis, NICE, Ozurdex, judicial review, market access, ophthamology
The chairman of NICE is advising campaigners to sue NHS bodies that block a treatment recommended by the watchdog.In a …
Latest content
Highlighting the value of lab research for healthcare innovation
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
